Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

More articles from Book Reviews

  • You have access
    Human Biochemistry. 1st Edition
    Anticancer Research May 2018, 38 (5) 3203;
  • You have access
    Tumor Organoids
    Anticancer Research May 2018, 38 (5) 3205;
  • You have access
    Cancer Stem Cells. Methods and Protocols
    Anticancer Research May 2018, 38 (5) 3203;
  • You have access
    Peptidomics of Cancer-Derived Enzyme Products, Volume 42. 1st Edition
    Anticancer Research May 2018, 38 (5) 3205-3206;
  • You have access
    Book Reviews
    Anticancer Research May 2018, 38 (5) 3203;
  • You have access
    Advances in Cell and Molecular Diagnostics. 1st Edition
    Anticancer Research May 2018, 38 (5) 3203-3204;
  • You have access
    Chromatin Proteins and Transcription Factors as Therapeutic Targets, Volume 107. 1st Edition
    Anticancer Research May 2018, 38 (5) 3205;
  • You have access
    Early Phase Cancer Immunotherapy
    Anticancer Research May 2018, 38 (5) 3204;
  • You have access
    Mims' Medical Microbiology and Immunology. 6th Edition
    Anticancer Research May 2018, 38 (5) 3204;
  • You have access
    MicroRNA and Cancer. Methods and Protocols
    Anticancer Research May 2018, 38 (5) 3203;

Pages

  • Previous
  • Next
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 113
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire